Serum AMH Levels: An Early Reproductive Marker for Bone Loss?

Visser, Jenny A.

doi:10.1002/jbmr.4567

Journal of Bone and Mineral Research

2020

DOI: 10.1002/jbmr.4567

|View full text |Cite

Serum AMH Levels: An Early Reproductive Marker for Bone Loss?

Jenny A. Visser

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 18 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Anti-Müllerian hormone: biology and role in endocrinology and cancers

Gowkielewicz,

Lipka,

Zdanowski

et al. 2024

Front. Endocrinol.

View full text Add to dashboard Cite

Anti-Müllerian hormone (AMH) is a peptide belonging to the transforming growth factor beta superfamily and acts exclusively through its receptor type 2 (AMHR2). From the 8th week of pregnancy, AMH is produced by Sertoli cells, and from the 23rd week of gestation, it is produced by granulosa cells of the ovary. AMH plays a critical role in regulating gonadotropin secretion, ovarian tissue responsiveness to pituitary hormones, and the pathogenesis of polycystic ovarian syndrome. It inhibits the transition from primordial to primary follicles and is considered the best marker of ovarian reserve. Therefore, measuring AMH concentration of the hormone is valuable in managing assisted reproductive technologies. AMH was initially discovered through its role in the degeneration of Müllerian ducts in male fetuses. However, due to its ability to inhibit the cell cycle and induce apoptosis, it has also garnered interest in oncology. For example, antibodies targeting AMHR2 are being investigated for their potential in diagnosing and treating various cancers. Additionally, AMH is present in motor neurons and functions as a protective and growth factor. Consequently, it is involved in learning and memory processes and may support the treatment of Alzheimer’s disease. This review aims to provide a comprehensive overview of the biology of AMH and its role in both endocrinology and oncology.

show abstract

Anti-Müllerian hormone: biology and role in endocrinology and cancers

Gowkielewicz,

Lipka,

Zdanowski

et al. 2024

Front. Endocrinol.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Serum AMH Levels: An Early Reproductive Marker for Bone Loss?

Cited by 1 publication

References 18 publications

Anti-Müllerian hormone: biology and role in endocrinology and cancers

Anti-Müllerian hormone: biology and role in endocrinology and cancers

Contact Info

Product

Resources

About